Funding supports Phase 2 trial of fibroblast-tar
Author: Michael
Ochre Bio launches Liver ICU, where drug candida
CND Life Sciences announced a $3 million grant aw
Lexington, Kentucky-based TruDiagnostic has repor
Toronto-based Lifeist Wellness Inc.
Biotechnology firm Alector said that its pivotal
Shedding light on how targeted wavelengths stimu
Company targets both clinical and wellness appli
Niklas Anzinger on the first-of-its-kind biomark
BCAM’s new campaign empowers patients to ask t